These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 8914117

  • 1. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
    Burnet PW, Eastwood SL, Harrison PJ.
    Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117
    [Abstract] [Full Text] [Related]

  • 2. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
    Sumiyoshi T, Ichikawa J, Meltzer HY.
    Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434
    [Abstract] [Full Text] [Related]

  • 3. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.
    Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE.
    Neuropsychopharmacology; 1993 Jun; 8(4):315-36. PubMed ID: 8512620
    [Abstract] [Full Text] [Related]

  • 4. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia.
    Burnet PW, Eastwood SL, Harrison PJ.
    Neurochem Int; 1997 Jun; 30(6):565-74. PubMed ID: 9152998
    [Abstract] [Full Text] [Related]

  • 5. Detection and quantitation of 5-HT1A and 5-HT2A receptor mRNAs in human hippocampus using a reverse transcriptase-polymerase chain reaction (RT-PCR) technique and their correlation with binding site densities and age.
    Burnet PW, Eastwood SL, Harrison PJ.
    Neurosci Lett; 1994 Aug 29; 178(1):85-9. PubMed ID: 7529388
    [Abstract] [Full Text] [Related]

  • 6. 5-HT transporter sites and 5-HT1A and 5-HT3 receptors in Fawn-Hooded rats: a quantitative autoradiography study.
    Chen F, Lawrence AJ.
    Alcohol Clin Exp Res; 2000 Jul 29; 24(7):1093-102. PubMed ID: 10924015
    [Abstract] [Full Text] [Related]

  • 7. Effects of maternal ethanol consumption and buspirone treatment on 5-HT1A and 5-HT2A receptors in offspring.
    Kim JA, Gillespie RA, Druse MJ.
    Alcohol Clin Exp Res; 1997 Oct 29; 21(7):1169-78. PubMed ID: 9347075
    [Abstract] [Full Text] [Related]

  • 8. Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors.
    Scandroglio A, Monferini E, Borsini F.
    Pharmacol Res; 2001 Feb 29; 43(2):179-83. PubMed ID: 11243720
    [Abstract] [Full Text] [Related]

  • 9. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia.
    Hashimoto T, Nishino N, Nakai H, Tanaka C.
    Life Sci; 1991 Feb 29; 48(4):355-63. PubMed ID: 1824956
    [Abstract] [Full Text] [Related]

  • 10. 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585.
    East SZ, Burnet PW, Leslie RA, Roberts JC, Harrison PJ.
    Synapse; 2002 Sep 01; 45(3):191-9. PubMed ID: 12112397
    [Abstract] [Full Text] [Related]

  • 11. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
    Kirchgessner AL, Liu MT, Howard MJ, Gershon MD.
    J Comp Neurol; 1993 Jan 08; 327(2):233-50. PubMed ID: 8425944
    [Abstract] [Full Text] [Related]

  • 12. Effect of chronic serotonin-2 receptor agonist or antagonist administration on serotonin-1A receptor sensitivity.
    Hensler JG, Truett KA.
    Neuropsychopharmacology; 1998 Nov 08; 19(5):354-64. PubMed ID: 9778658
    [Abstract] [Full Text] [Related]

  • 13. Regional changes in 5-HT1A but not in 5-HT2A receptors in mouse brain after Semliki Forest virus infection: radioligand binding and autoradiographic studies.
    Mehta S, Kitchen I.
    J Neurovirol; 1998 Dec 08; 4(6):606-18. PubMed ID: 10065902
    [Abstract] [Full Text] [Related]

  • 14. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
    Tilakaratne N, Friedman E.
    Eur J Pharmacol; 1996 Jun 27; 307(2):211-7. PubMed ID: 8832223
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I, Johansson C, Ogren SO.
    Br J Pharmacol; 1998 Oct 27; 125(3):499-509. PubMed ID: 9806333
    [Abstract] [Full Text] [Related]

  • 16. Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat.
    Burnet PW, Mefford IN, Smith CC, Gold PW, Sternberg EM.
    J Neurochem; 1992 Sep 27; 59(3):1062-70. PubMed ID: 1379629
    [Abstract] [Full Text] [Related]

  • 17. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

  • 18. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H.
    J Pharmacol Exp Ther; 1994 Mar 12; 268(3):1432-43. PubMed ID: 8138956
    [Abstract] [Full Text] [Related]

  • 19. The effects of clozapine and haloperidol on serotonin-1A, -2A and -2C receptor gene expression and serotonin metabolism in the rat forebrain.
    Burnet PW, Chen CP, McGowan S, Franklin M, Harrison PJ.
    Neuroscience; 1996 Jul 12; 73(2):531-40. PubMed ID: 8783268
    [Abstract] [Full Text] [Related]

  • 20. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
    Mokrosz MJ, Kowalski P, Kowalska T, Majka Z, Duszyńska B, Charakchieva-Minol S, Szaro A, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 1998 Jul 12; 50(4-5):333-40. PubMed ID: 10091718
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.